BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55


SEARCH JOBS




Industry
Biotechnology






 Company News
Epigenomics AG Reports Results For The Financial Year Ended December 31, 2014 And Provides Outlook For 2015 3/25/2015 1:50:17 PM
Epigenomics AG Announces Completion Of Enrollment In Epi proColon ADMIT Trial 3/25/2015 10:01:40 AM
First Patients Enrolled In Epigenomics AG’ Epi proColon® ADMIT Study 12/17/2014 1:09:07 PM
Epigenomics AG To Present At Oppenheimer 25th Annual Healthcare Conference 12/10/2014 1:05:55 PM
Epigenomics AG And BioChain Announce Approval Of Epi proColon® In China 12/8/2014 2:09:18 PM
Epigenomics AG Announces 2014 Third Quarter And Nine Month Financial Results And Reports On Operational Highlights 11/11/2014 11:38:02 AM
Epigenomics AG’ Strategic Commercialization Partner Polymedco Reiterates Its Commitment To Support Epi proColon® In The United States 11/3/2014 1:11:36 PM
Results Of Adherence Study Published In BMC Gastroenterology Demonstrate That Epigenomics AG’ Blood-Based Epi Procolon® Improves Compliance To CRC Screening 10/27/2014 9:34:11 AM
Epigenomics AG Raises USD 5.3 Million From Its Strategic Commercialization Partner Biochain Institute, Inc. 10/16/2014 2:00:29 PM
Epigenomics AG Provides Corporate Update 10/1/2014 10:38:04 AM
12345678910...